mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 30 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 353,601 | 0 | C | A | 59.3% | ‑4.9 / 22.0 | 27 | L267F (TTG→TTT) | cynR | transcriptional regulator CynR |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 58.6% | ‑5.9 / 25.1 | 29 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 58.6% | ‑5.7 / 24.6 | 29 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 937,169 | 0 | T | G | 58.3% | ‑2.2 / 10.5 | 12 | V252G (GTG→GGG) | dmsA | dimethylsulfoxide reductase subunit A |
| * | NZ_CP009273 | 1,152,727 | 0 | T | G | 57.1% | 4.3 / 12.1 | 14 | G165G (GGT→GGG) | ycfH | metal‑dependent hydrolase |
| * | NZ_CP009273 | 4,297,122 | 0 | A | C | 57.1% | 7.1 / 13.3 | 14 | G165G (GGT→GGG) | alsK | allose kinase |
| * | NZ_CP009273 | 381,253 | 0 | T | G | 56.2% | 8.6 / 17.1 | 16 | V189G (GTG→GGG) | tauA | taurine ABC transporter substrate‑binding protein |
| * | NZ_CP009273 | 1,622,316 | 0 | T | G | 56.2% | 8.3 / 14.8 | 16 | G181G (GGT→GGG) | ydfG | bifunctional NADP‑dependent 3‑hydroxy acid dehydrogenase/3‑hydroxypropionate dehydrogenase YdfG |
| * | NZ_CP009273 | 1,622,307 | 0 | T | G | 55.6% | 11.3 / 16.7 | 18 | G178G (GGT→GGG) | ydfG | bifunctional NADP‑dependent 3‑hydroxy acid dehydrogenase/3‑hydroxypropionate dehydrogenase YdfG |
| * | NZ_CP009273 | 3,090,826 | 0 | T | G | 55.6% | 11.1 / 16.2 | 18 | G67G (GGT→GGG) | hemW | radical SAM family heme chaperone HemW |
| * | NZ_CP009273 | 4,558,321 | 0 | T | G | 55.6% | 22.4 / 32.0 | 27 | T6P (ACC→CCC) | mdtM | multidrug efflux MFS transporter MdtM |
| * | NZ_CP009273 | 2,380,347 | 0 | T | A | 54.5% | 2.1 / 10.6 | 11 | intergenic (+37/‑66) | yfbL/yfbM | M28 family metallopeptidase/YfbM family protein |
| * | NZ_CP009273 | 2,380,357 | 0 | A | T | 54.5% | 2.6 / 10.6 | 11 | intergenic (+47/‑56) | yfbL/yfbM | M28 family metallopeptidase/YfbM family protein |
| * | NZ_CP009273 | 1,673,569 | 0 | A | C | 53.8% | 7.3 / 11.4 | 13 | T296P (ACC→CCC) | ydgH | DUF1471 family protein YdgH |
| * | NZ_CP009273 | 3,126,661 | 0 | T | G | 53.8% | 3.7 / 13.8 | 13 | H219P (CAC→CCC) | yghS | dTMP kinase |
| * | NZ_CP009273 | 4,058,967 | 0 | T | C | 53.8% | 11.1 / 16.4 | 13 | I54V (ATT→GTT) | yihO | MFS transporter |
| * | NZ_CP009273 | 3,562,123 | 0 | A | T | 53.3% | 8.0 / 17.9 | 15 | I189N (ATT→AAT) | glgC | glucose‑1‑phosphate adenylyltransferase |
| * | NZ_CP009273 | 3,924,078 | 0 | T | G | 53.3% | 4.2 / 12.6 | 15 | T126P (ACC→CCC) | ravA | ATPase RavA |
| * | NZ_CP009273 | 3,300,628 | 0 | T | G | 52.9% | 31.1 / 42.6 | 34 | T198P (ACC→CCC) | deaD | ATP‑dependent RNA helicase DeaD |
| * | NZ_CP009273 | 4,351,348 | 0 | T | G | 52.9% | 2.1 / 15.3 | 17 | H135P (CAC→CCC) | cadC | lysine decarboxylation/transport transcriptional activator CadC |